Bioinformatic analysis and experiments on clinical samples and mouse models of breast cancer unveil a new signaling protein degradation pathway involving TRIM59 and PDCD10 that modulates breast cancer cell growth, survival, and metastasis. Here, TRIM59 is linked to breast carcinoma.